Bayer CropScience Reports Financial Results for Quarter Ending December 31, 2025

Bayer CropScience Limited has announced its Unaudited Financial Results for the quarter and nine months ending December 31, 2025. The Board of Directors approved these results following a limited review by the statutory auditors. Key financial metrics indicate fluctuations in quarterly performance, with Profit Before Tax for the quarter at ₹1,130 million, compared to ₹336 million in the corresponding quarter last year. Earnings Per Share (Basic/Diluted) for the quarter stood at ₹21.29.

Unaudited Financial Results Approval

The Board of Directors of Bayer CropScience Limited convened on February 11, 2026, to approve the Unaudited Financial Results for the quarter and the nine months ended December 31, 2025. The meeting commenced at 4:15 p.m. IST and concluded at 5:15 p.m. IST.

Quarterly Financial Performance (Q3 FY26)

The company’s financial statement, presented in millions of ₹, highlights the following for the quarter ended December 31, 2025:

  • Total Income was ₹11,221 million.
  • Total Expenses amounted to ₹10,091 million.
  • Profit Before Tax stood at ₹1,130 million, significantly up from ₹336 million in the corresponding quarter ended December 31, 2024.
  • Profit for the period/year was ₹957 million.
  • Earnings Per Share (basic and diluted, not annualised) was ₹21.29^, compared to ₹7.61^ in Q3 FY25.

Nine Months Ended Performance

For the cumulative nine months ended December 31, 2025:

  • Total Income reached ₹46,226 million.
  • Total Expenses were reported at ₹39,741 million.
  • Profit Before Tax was ₹6,485 million.
  • Profit for the period/year was ₹5,271 million, up from ₹4,247 million in the previous year.
  • Earnings Per Share (basic and diluted, not annualised) for the nine months was ₹117.28^.

Other Key Disclosures

The company noted that it operates under a single reportable business segment, which is “Agri Care.” Furthermore, the results have been subjected to a limited review by the Statutory Auditors, Deloitte Haskins & Sells LLP.

The company confirmed that the incremental impact arising from the new Labour Codes on employee benefit obligations, based on available information as of the reporting date, is not material and has been accounted for in the financial results.

Source: BSE

Previous Article

Orchid Pharma Limited Board Approves Unaudited Financial Results for Q3 FY2025 and Review Reports

Next Article

Hindalco Industries Novelis Reports Q3FY26 Results Amid Oswego Production Disruption